Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and ...
ERS Genomics Limited ('ERS Genomics'), the CRISPR licensing company, today announced that it has signed a non-exclusive ...
A 2026 review summarizes advances in CRISPR-Cas9 precision, delivery and primary-cell engineering for genetic diseases and ...
Programs span familial and sporadic ALS, advancing Arbor’s strategic focus on the diseaseFirst CNS investigational new drug ...
Infant neuroblastoma is one of the most clinically paradoxical cancers in medicine. Diagnosed during the first year of life, ...
Huntington's disease is caused by repetitive "stutters" in DNA—specifically repeated CAG sequences—that expand abnormally over time, leading to toxic protein accumulation that contributes to the ...
What If on MSNOpinion
What if we could genetically engineer the perfect human, and what would it cost us?
What makes the perfect human? Immaculate features? Indomitable Intelligence? Incomparable wit? Or irresistible charm? What if ...
Learn when TIDE-based Sanger sequencing can replace NGS for measuring on-target gene editing efficiency in regulated ...
Raju has been a trusted partner to me and a wonderful colleague during his time at CRISPR Therapeutics," said Samarth ...
According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48 billion in ...
The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice ...
Emerging approaches can help detect off-target effects in base editing. In silico, in vitro, and cell-based methods can all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results